Hepatitis Weekly articles from November 2008

Hepatitis Weekly archives from November 2008

Are bone marrow mononuclear cells effective in reducing hepatic lesions?
November 3, 2008... Liver fibrosis occurs in the setting of chronic injury caused by different etiologies constituting a serious worldwide public health problem. In addition to schistosomiasis, hepatopathies due to alcohol, viral hepatitis, drugs, metabolic and...

The risk factors of idiopathic pulmonary fibrosis in HCV patients.
November 3, 2008... Hepatitis C virus (HCV) is one of the more common causes of chronic liver disease in world with a variety of extrahepatic complications such as essential mixed cryoglobulinemia, membranoproliferative glomerulonep hritis, autoimmune thyroiditis,...

New chronic hepatitis research from G.L.H. Wong and colleagues discussed.
November 3, 2008... "Liver stiffness measurement (LSM) with transient elastography (Fibroscan) can accurately diagnose advanced liver fibrosis, but its performance in early liver fibrosis is less satisfactory. We aimed to study the diagnostic performance of LSM...

New fibrosis research from L. Aoudjehane et al outlined.(Report)
November 3, 2008... According to recent research from Paris, France, "Interleukin-4 (IL-4) is overexpressed in liver grafts in a context of severe recurrent hepatitis C, during which the development of fibrosis is dramatically accelerated. In this study, we...

Studies from University of Gdansk describe new findings in gene therapy.
November 3, 2008... According to recent research published in the journal Medical Science Monitor, "The proper application of quantitative real-time reverse transcription polymerase chain reaction (RT-PCR) for the relative quantification of a target gene in gene...

Study findings from E.J. Theve et al broaden understanding of hepatitis.
November 3, 2008... According to a study from the United States, "Hepatitis B virus (HBV), the leading cause of human hepatocellular carcinoma, is especially virulent in males infected at an early age. Likewise, the murine liver carcinogen Helicobacter hepaticus...

Study results from C.S. Guy and colleagues update understanding of hepatitis.(Report)
November 3, 2008... "The importance of effective immune responses in recovery from acute hepadnaviral hepatitis has been demonstrated. However, there is no conclusive delineation of virological and immunological events occurring in the liver immediately after...

Data on hepatitis A virus described by M.J. Snooks et al.
November 3, 2008... According to a study from Melbourne, Australia, "Hepatitis A virus (HAV) is an enterically transmitted virus that replicates predominantly in hepatocytes within the liver before excretion via bile through feces. Hepatocytes are polarized...

New hepatitis A virus research has been reported by D.R.L. Dossantos et al.
November 3, 2008... "From December 1999 to December 2001, many cases of hepatitis A were notified in the county of Belford Roxo involving individuals aged 0 to 79 years. Serum samples were collected to evaluate the prevalence of anti-hepatitis A virus (HAV)...

Data on hepatitis B virus reported by researchers at University of Munich.
November 3, 2008... " RNA interference based therapeutic approaches hold promise for the treatment of patients chronically infected with hepatitis B virus (HBV). To conquer HBV infection, long-term suppression of target transcripts in all hepatocytes without toxic...

Findings from H.L.Y. Chan et al in hepatitis B virus reported.
November 3, 2008... "We aimed to investigate the early on-treatment HBV DNA response to predict sustained virologic response for peginterferon and lamivudine combination therapy. Patients recruited in previous clinical trials receiving 32-week peginterferon...

New hepatitis B virus study results reported from University of Antwerp.
November 3, 2008... "The hepatitis B virus core (HBc) virus-like particle (VLP) is known as one of the most immunogenic antigens and carrier vehicles in different immunization strategies. Recent findings are suggesting the potential of the HBc VLPs as an oral...

Reports outline hepatitis B virus study findings from INSERM.(Report)
November 3, 2008... According to a study from Lyon, France, "Complete characterization of the biological properties of hepatitis B virus (HBV) variants requires the generation of full-length genomes. The aim of this study was to develop new tools for the efficient...

Study data from J.C. Forbi and co-authors update knowledge of hepatitis B virus.(Report)
November 3, 2008... "Hepatitis B Virus (HBV) infection is endemic in Nigeria and Constitutes it public health menace. The prevalence of HBV infection in many professional groups has been described in Nigeria," scientists in Nigeria report (see also Hepatitis B...

Data from Cork University provide new insights into hepatitis C virus.(Report)
November 3, 2008... "Pre-treatment HCV quasispecies complexity and diversity may predict response to interferon based anti-viral therapy. The objective of this study was to retrospectively (1) examine temporal changes in quasispecies prior to the start of therapy...

Findings in hepatitis C virus reported from J.E. Mathy and co-researchers.
November 3, 2008... "Chronic hepatitis C virus (HCV) infection remains a major global health burden while current interferon-based therapy is suboptimal. Efforts to develop more effective antiviral agents mainly focus on two viral targets: NS3-4A protease and NS5B...

Iwate Medical University reports research in hepatitis C virus.
November 3, 2008... According to a study from Japan, "Patients with chronic hepatitis C viral infection underwent liver biopsies and laboratory studies for evaluation and to determine subsequent treatment. Changes in status of drug metabolism and disposition may...

New research on hepatitis C virus from University of Jena summarized.(Report)
November 3, 2008... "The aim of this Study was to analyze the impact of virological response to long-term antiviral therapy using interferon plus ribavirin on survival of 30 liver transplant patients with recurrent hepatitis C. Mean treatment duration is currently...

Reports summarize hepatitis C virus study results from Osaka University.(Report)
November 3, 2008... "Hepatitis C virus (HCV) core protein has shown to be localized in the detergent-resistant membrane (DRM), which is distinct from the classical raft fraction including caveolin, although the biological significance of the DRM localization of...

Research conducted at C.K. Lai and co-researchers has updated our knowledge about hepatitis C virus.
November 3, 2008... According to recent research from Taipei, Taiwan, "The hepatitis C virus (HCV) RNA replication complex (RC), which is composed of viral nonstructural (NS) proteins and host cellular proteins, replicates the viral RNA genome in association with...

Research conducted at INSERM has provided new information about hepatitis C virus.
November 3, 2008... "The mechanisms underlying hepatitis C virus (HCV) morphogenesis remain elusive, but lipid droplets have recently been shown to be important organelles for virus production," scientists writing in the journal Histochemistry and Cell Biology...

Research from University of Tennessee reveals new findings on hepatitis C virus.
November 3, 2008... According to a study from the United States, "In this article, we explore the virological response to two types of interferon based treatment in recurrent hepatitis C virus in liver recipients who received thymoglobulin induction. Fifty...

Research on hepatitis C virus published by scientists at Novartis.
November 3, 2008... "Infection with hepatitis C virus (HCV) is still a major public health problem, and the events leading to hepatocyte infection are not yet fully understood," investigators in Siena, Italy report (see also Hepatitis C Virus). "Combining...

Researchers at Tibotec release new data on hepatitis C virus.
November 3, 2008... "HCV-796 selectively inhibits hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase. In hepatoma cells containing a genotype 1b HCV replicon, HCV-796 reduced HCV RNA levels by 3 to 4 log(10) HCV copies/mu g total RNA (the concentration of...

Data from W.P. Hu et al provide new insights into hepatitis E virus.
November 3, 2008... According to a study from People's Republic of China, "A new double-antigen sandwich-based enzyme-linked immunosorbent assay (ELISA) for the detection of total antibodies (immunoglobulin G [IgG] and IgM) specific for hepatitis E virus (HEV) was...

Reports outline hepatitis E virus study results from F.B. Riquet et al.
November 3, 2008... According to recent research from Paris, France, "Pathogenic circulating vaccine-derived polioviruses (cVDPVs) have become a major obstacle to the successful completion of the global polio eradication program." "Most cVDPVs are recombinant...

Research findings from Odense University update understanding of hepatitis E virus.(Report)
November 3, 2008... "Antibody to hepatitis E virus (anti-HEV) is prevalent in Western countries, where clinical hepatitis E is rarely reported. The aim of this study was to determine the prevalence of anti-HEV among Danish blood donors and Danish farmers,"...

Findings from E.G. Fernandez and co-authors provide new insights into monoclonal antibodies.
November 3, 2008... According to a study from Havana, Cuba, "The partial least square technique (PLS) was applied to the monoclonal antibody (Mab) CB.Hep-1 immunosorbent manufacturing to determine the influence of cyanate ester concentration, ligand concentration...

Research results from S.J. Schrieber and co-authors update knowledge of pharmacokinetics.(Report)
November 3, 2008... According to recent research from the United States, "Silymarin, used by 30 to 40% of liver disease patients, is composed of six major flavonolignans, each of which may contribute to silymarin's hepatoprotective properties. Previous studies...

New thrombocytopenia study findings recently were reported by researchers at University of Genoa.
November 3, 2008... According to a study from Genoa, Italy, "Purpose of review To evaluate recent findings in the multifaceted pathophysiological mechanisms underlying thrombocytopenia in patients with chronic liver disease and to assess its therapeutic...

Study data from University of Thessaly, Department of Medicine update knowledge of alcoholism immunology.(Report)
November 3, 2008... New research, 'IgA anti-b2GPI antibodies in patients with autoimmune liver diseases,' is the subject of a report. "Recently, we reported a high prevalence of immunoglobulin G and/or immunoglobulin M anticardiolipin antibodies (aCL) in patients...

Researchers at University of Washington target hepatitis.
November 3, 2008... Current study results from the report, 'Chronic liver disease in Aboriginal North Americans,' have been published. According to a study from the United States, "A structured literature review was performed to detail the frequency and etiology...

Investigators at Osaka University target hepatitis B virus therapy.
November 3, 2008... A new study, 'Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus,' is now available. "Hepatitis B virus (HBV) establishes lamivudine resistance via the resistance-causative...

New hepatitis B virus therapy research from Drexel University, Institute for Molecular Medicine discussed.(Report)
November 3, 2008... Research findings, 'Vector design for liver-specific expression of multiple interfering RNAs that target hepatitis B virus transcripts,' are discussed in a new report. According to recent research published in the journal Antiviral Research,...

Scientists at Xi'an Jiao Tong University, Department of Endocrinology target hepatitis B virus therapy.
November 3, 2008... Data detailed in 'Abrupt onset of type 1 diabetes mellitus during recombinant interferon-alpha 2b therapy in a patient with chronic hepatitis B' have been presented. "We describe a case of a 33-year-old female patient with chronic hepatitis B...

Findings in hepatitis C virus reported from University of Crete, Faculty of Medicine.
November 3, 2008... Fresh data on hepatitis C virus are presented in the report 'Mannose-binding lectin MBL2 gene polymorphisms and outcome of hepatitis C virus-infected patients.' According to recent research from Greece, "Mannose-binding lectin (MBL) is involved...

Investigators at University of Modena zero in on hepatitis C virus therapy.
November 3, 2008... A report, 'Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection,' is newly published data in Journal of Rheumatology. "The prevalence of concurrent rheumatoid arthritis...

Research from P. An and co-authors provides new data about hepatitis C virus therapy.(Report)
November 3, 2008... Scientists discuss in 'Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance' new findings in hepatitis C virus. "The immune response is critical in determining the outcome of hepatitis C virus...

Research from P. Cacoub and co-authors yields new data on hepatitis C virus therapy.(Clinical report)
November 3, 2008... New investigation results, 'Hepatitis C virus infection induced vasculitis,' are detailed in a study published in Clinical Reviews In Allergy and Immunology. "Cryoglobulinemia are immune complexes that may induce systemic cryoglobulinemic...

Research results from University Federal of Rondonia update knowledge of vaccines.
November 3, 2008... A new study, 'Principal component analysis and discrimination of variables associated with pre- and post-natal exposure to mercury,' is now available. According to recent research from Porto Velho, Brazil, "The variance of variables associated...

Research results from Y.H. Hu and colleagues update understanding of chronic hepatitis.
November 3, 2008... According to recent research published in the journal Amino Acids, "The effect of dietary amino acid taurine on the liver function of chronic hepatitis patients was investigated. The 24 chronic hepatitis patients with 2-5 times over normal...

Research data from Virginia Commonwealth University update understanding of hepatitis.
November 3, 2008... "Standard treatment for autoimmune hepatitis (AIH) involves immune suppression by using prednisone alone or in combination with azathioprine (AZA). Although this regimen achieves remission in approximately 80%, some patients are intolerant or...

Research reports from Thomas Jefferson University provide new insights into neuritis.
November 3, 2008... "Optic neuritis (ON), an inflammatory demyelinating optic nerve disease, occurs in multiple sclerosis (MS). Pathological mechanisms and potential treatments for ON have been studied via experimental autoimmune MS models," scientists in the...

Studies from Shanghai Institutes for Biological Sciences in the area of hepatitis immunology described.(Report)
November 3, 2008... Investigators publish new data in the report 'Sodium tanshinone IIA sulfonate protects mice from ConA-induced hepatitis via inhibiting NF-kappaB and IFN-gamma/STAT1 pathways.' According to a study from Shanghai, People's Republic of China,...

Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH).
November 3, 2008... Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (BULLETIN BOARD: RPTP) , announced the initiation of patient dosing in a Phase 2a clinical trial, in collaboration with the University of California, San Diego ("UCSD"), to evaluate...

Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights.(Financial report)
November 3, 2008... Anadys Pharmaceuticals, Inc. (NASDAQ:ANDS), a clinical-stage biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology, reported its financial results and highlights for...

Anadys Pharmaceuticals to Present at BIOCOM Investor Conference 2008.(Conference news)
November 3, 2008... Anadys Pharmaceuticals, Inc. (NASDAQ:ANDS) announced that it will present at the 3rd annual BIOCOM Investor Conference on Monday, October 27, 2008 at 11:30 a.m. PDT (2:30 p.m. EDT) at the Hyatt Regency La Jolla in San Diego, California (see...

Ener1 to Participate at Jefferies 6th Global Clean Technology Conference and the Gabelli 32nd Annual Automotive Aftermarket Symposium.(Conference news)
November 3, 2008... Ener1, Inc. (AMEX:HEV), announced its participation at the Jefferies 6th Global Clean Technology Conference, to be held in London, England. Charles Gassenheimer, Chairman and CEO of Ener1, will present this Wednesday, October 22 at 10:45 a.m....

Freescale Debuts World's Most Powerful Automotive Microcontroller for 'Green' Engine Design.
November 3, 2008... Faced with soaring fuel prices and pressures to curb greenhouse gases, automakers are racing to design vehicles that deliver better fuel economy and reduced emissions. High-performance microcontrollers (MCUs) play a key role in green automotive...

Hitachi Awarded Order from Eaton Corporation for Commercial Vehicle Hybrid System.
November 3, 2008... Hitachi, Ltd. (NYSE:HIT)(TOKYO:6501) and Hitachi Vehicle Energy, Ltd., which manufactures lithium-ion batteries for hybrid electric vehicles (HEV) and other uses, announced that they have been awarded an order from U.S.-based Eaton Corporation...

Adult liver transplant eligibility criteria.
November 3, 2008... The pain is debilitating. The only option: smoking medical marijuana. That's the reality for many hepatitis C patients whose road to health includes a liver transplant. Although Canadian transplant centres are more willing than those in the...

If the diabetes has a direct carcinogenetic effect?
November 10, 2008... The association of DM2 with solid tumors, and particularly with HCC, has been long suspected and several studies have reported increased mortality rates for neoplastic diseases in patients with DM2. However, the temporal relationship between...

Research on atherosclerosis discussed by scientists at University of Padua.
November 10, 2008... "Haemophilia patients may develop cardiovascular diseases, Suggesting that their clotting defect does not protect them completely from atherosclerosis and its complications. We aimed to evaluate cardiovascular risk factors and, for the first...

Cytheris Initiates Asian Phase I/IIa Clinical Trial of Interleukin-7 IL-7 as an Immunotherapy in HCV Patients.(Report)
November 10, 2008... Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, announced the initiation of a multicenter Phase I/IIa dose escalation study in Taiwan. This study will assess...

Study results from University of Ulm update understanding of DNA vaccines.
November 10, 2008... "We investigated whether the immunogenicity of antigens delivered by recombinant E1-deleted adenovirus (Ad) is impaired by the concomitant priming of specific immunity to protein antigens of the vector. A comparative evaluation of the...

Research from Tohoku University provide new insights into hepatitis.
November 10, 2008... "Many studies have reported the efficiency of transient elastography, a noninvasive, reproducible, and reliable method for predicting liver fibrosis, in patients with chronic hepatitis C (CHC) and B (CHB), but there are few reports about...

Researchers from Taipei Veterans General Hospital publish new studies and findings in the area of hepatitis.
November 10, 2008... According to a study from Taipei, Taiwan, "The organ shortage and high prevalence of hepatitis B (HB) infection in the general population are important issues in Taiwan. It is difficult for us to abandon HBsAg(+) donors." "Hereby we...

Findings from Chiba University, Medical Department broaden understanding of hepatitis B virus.(Report)
November 10, 2008... "Patients with severe exacerbation of chronic hepatitis B, sometimes developing into fulminant liver failure, are at high risk for mortality even with antiviral therapy. The efficacy of immunosuppressive therapy in clinically severe...

Research from Chang-Gung University provide new insights into hepatitis B virus.
November 10, 2008... "Renal transplant recipients display an increased risk of malignancy due to long-term immunosuppression. The type and incidence of malignancies vary geographically," scientists in Taiwan report (see also Hepatitis B Virus). "Hepatocelluar...

Research from M.A. Matos and colleagues provide new insights into hepatitis B virus.
November 10, 2008... In this recently published article, scientists in Goiania, Brazil conducted a study "To investigate the epidemiology of hepatitis B virus (HBV) infection and viral genotypes in long distance truck drivers in Brazil. We interviewed 641 long...

Research from Taipei Veterans General Hospital yields new data on hepatitis B virus.
November 10, 2008... According to recent research from Taipei, Taiwan, "Late spontaneous kidney graft decapsulation with fluid collection is a rare condition with only a few cases reported in the literature. Common causes of renal allograft rupture include acute...

Research from Z.J. Yu and colleagues provide new insights into hepatitis B virus.
November 10, 2008... According to a study from Guangzhou, People's Republic of China, "Multiple studies have established that GTPase activity is critical for MxA to act against RNA viruses." "Recently, it was shown that MxA can also restrict the replication of...

Researchers at University Hospital target hepatitis B virus.
November 10, 2008... "The aim of our study was to assess the efficacy and safety of entecavir in kidney- and liver-transplant recipients with chronic hepatitis B virus (HBV) infection. Ten male transplant patients with chronic HBV infection (eight kidney- and two...

New hepatitis C virus study findings have been reported by J. Lara and co-researchers.
November 10, 2008... According to recent research published in the journal Bioinformatics, "Insufficient knowledge of general principles for accurate quantitative inference of biological properties from sequences is a major obstacle in the rationale design of...

New hepatitis C virus study findings recently were reported by T. Huang and co-researchers.
November 10, 2008... "The status of a disease can be reflected by specific transcriptional profiles resulting from the induction or repression activity of a number of genes. Here, we proposed a time-dependent diagnostic model to predict the treatment effects of...

New hepatitis C virus study results reported from Federal University.
November 10, 2008... "Hepatitis C, a worldwide viral infection, is an important health problem in Brazil. The virus causes chronic infection, provoking B lymphocyte dysfunction, as represented by cryoglobulinemia, non-organ-specific autoantibody production, and...

Research on hepatitis C virus described by A. Manzur and colleagues.
November 10, 2008... "Necrolytic acral erythema is a relatively recently described psoriasis-like skin eruption seen in people infected with hepatitis C virus," investigators in Sargodha, Pakistan report (see also Hepatitis C Virus). "Hepatitis C virus...

Researchers from Tokyo Women's Medical University report on findings in hepatitis C virus.(Report)
November 10, 2008... "The purpose of this study was to analyze the effects of immunosuppressants on hepatitis C virus (HCV) replication to establish optimal immunosuppressive therapy in HCV-positive renal transplantation. Cyclosporine (CsA), tacrolimus (Tac),...

Studies from M. Minz and co-authors have provided new information about hepatitis C virus.(Report)
November 10, 2008... According to a study from Chandigarh, India, "Hepatitis C virus (HCV) infection remains an important risk factor for mortality and morbidity in transplant recipients. In this study, we retrospectively analyzed the impact of pretransplantation...

Research on hepatocellular cancer discussed by T.C. Liu and co-researchers.
November 10, 2008... "JX-594 is a targeted oncolytic poxvirus that is designed to eradicate cancer cells having cell-cycle defects, through replication, cell lysis, and spread within tumors; oncolysis-induced tumor vascular shutdown and immunostimulation are...

Study data from P. Lagiou et al provide new insights into hepatocellular cancer.(Report)
November 10, 2008... According to recent research published in the journal Cancer Causes & Control, "In the context of a case-control study undertaken in Greece, we examined the role of six flavonoid classes in the etiology of hepatocellular carcinoma (HCC), by...

Investigators at Stanford University zero in on life sciences.
November 10, 2008... According to recent research from the United States, "It has been observed that overexpression of some short-hairpin RNAs (shRNAs) can induce acute cytotoxicity. This has raised concerns about the safety of using RNA interference (RNAi)...

Research from University of Bari yields new findings on acute hepatitis therapy.(Report)
November 10, 2008... Research findings, 'Acute hepatitis C: current status and remaining challenges,' are discussed in a new report. "The acute phase of hepatitis C virus (HCV) infection represents a key point in the evolution of hepatitis C. In some patients, the...

New DNA research study findings recently were reported by researchers at Purdue University, Department of Basic Medical Sciences.
November 10, 2008... Current study results from the report, 'Hepatitis B virus X protein increases the Cdt1-to-geminin ratio inducing DNA re-replication and polyploidy,' have been published. According to recent research from the United States, "Hepatitis B virus X...

Studies from Nanjing Medical University, Vaccine Research Center reveal new findings on DNA vaccines.(Report)
November 10, 2008... Research findings, 'The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen,' are discussed in a new report. According to...

Studies from New York Medical College update current data on enzyme research.
November 10, 2008... Researchers detail in 'Monitoring helicase activity with molecular beacons,' new data in enzyme research. "A high-throughput, fluorescence-based helicase assay using molecular beacons is described. The assay is tested using the NS3 helicase...

Research from University of Tokyo, Department of Gastroenterology provide new insights into gastroenterology.
November 10, 2008... Researchers detail in 'Comparison of liver biopsy and transient elastography based on clinical relevance,' new data in gastroenterology. According to a study from Tokyo, Japan, "Liver stiffness measurement (LSM) by transient elastography has...

New hepatitis B virus study findings reported from University of Madras, Dr. ALM Post Graduate Institute of Basic Medical Sciences.
November 10, 2008... Fresh data on hepatitis B virus are presented in the report 'The prevalence of hepatitis B virus and hepatitis C virus infection among patients with chronic liver disease in South India.' According to recent research published in the...

New hepatitis B virus study results from Johann Wolfgang Goethe University described.
November 10, 2008... New investigation results, 'Mammalian BiP controls posttranslational ER translocation of the hepatitis B virus large envelope protein,' are detailed in a study published in FEBS Letters. "The hepatitis B virus L protein forms a dual topology in...

Research from National Health Service reveals new findings on hepatitis B virus.
November 10, 2008... Data detailed in 'Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains' have been presented. According to recent research from Cambridge, the United Kingdom, "Nucleic acid testing (NAT) for...

Reports from University of Ferrara highlight recent research in hepatitis B virus therapy.
November 10, 2008... Researchers detail in 'The management of viral hepatitis in CKD patients: an unresolved problem,' new data in hepatitis B virus. According to a study from Ferrara, Italy, "Chronic kidney disease (CKD) patients in dialysis (HD) show peculiar,...

Study findings on hepatitis B virus therapy are outlined in reports from University of Frankfurt.
November 10, 2008... New investigation results, 'Treatment predictors of a sustained virologic response in hepatitis B and C,' are detailed in a study published in Journal of Hepatology. According to a study from Frankfurt am Main, Germany, "Treatment predictors...

New hepatitis B virus vaccines study findings have been published by K.E. El Beltagy and colleagues.(Survey)(Clinical report)
November 10, 2008... New research, 'Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia,' is the subject of a report. "This study was carried out to determine the prevalence of hepatitis B virus...

New findings reported from University of Heidelberg, Department of Molecular Virology describe advances in hepatitis C virus.
November 10, 2008... Scientists discuss in 'Structural and functional characterization of nonstructural protein 2 for its role in hepatitis C virus assembly' new findings in hepatitis C virus. "The hepatitis C virus (HCV) is a flavivirus replicating in the...